CELLECTIS.COM: Keyword Density Checker

Total words: 2436 | 2-word phrases: 621 | 3-word phrases: 697 | 4-word phrases: 747

PAGE INFO

Title	Try to keep the title under 60 characters (16 characters) Home \| Cellectis
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (21 characters) Commitment to a Cure

#	Keyword	Frequency	Density
1	clinical data on	14	2.01%
2	clls a clinicalstage	12	1.72%
3	more all press	12	1.72%
4	nasdaq clls a	12	1.72%
5	york ny –	12	1.72%
6	new york ny	12	1.72%
7	pioneering geneediting platform	12	1.72%
8	geneediting platform to	12	1.72%
9	company using its	12	1.72%
10	develop lifesaving cell	12	1.72%
11	all press releases	12	1.72%
12	biotechnology company using	12	1.72%
13	read more all	12	1.72%
14	lifesaving cell and	12	1.72%
15	cell and gene	12	1.72%
16	euronext growth alclsnasdaq	10	1.43%
17	growth alclsnasdaq clls	10	1.43%
18	alclsnasdaq clls a	10	1.43%
19	using its pioneering	10	1.43%
20	its pioneering geneediting	10	1.43%
21	euronext growth alcls	10	1.43%
22	ny – cellectis	10	1.43%
23	cellectis the “company”	10	1.43%
24	preclinical data on	10	1.43%
25	and gene therapies	10	1.43%
26	– cellectis the	8	1.15%
27	data on a	8	1.15%
28	an oral presentation	8	1.15%
29	presentation and two	6	0.86%
30	poster presentations at	6	0.86%

#	Keyword	Frequency	Density
1	nasdaq clls a clinicalstage	12	1.61%
2	biotechnology company using its	12	1.61%
3	read more all press	12	1.61%
4	more all press releases	12	1.61%
5	lifesaving cell and gene	12	1.61%
6	develop lifesaving cell and	12	1.61%
7	pioneering geneediting platform to	12	1.61%
8	new york ny –	12	1.61%
9	cell and gene therapies	10	1.34%
10	its pioneering geneediting platform	10	1.34%
11	alclsnasdaq clls a clinicalstage	10	1.34%
12	growth alclsnasdaq clls a	10	1.34%
13	euronext growth alclsnasdaq clls	10	1.34%
14	using its pioneering geneediting	10	1.34%
15	york ny – cellectis	10	1.34%
16	company using its pioneering	10	1.34%
17	ny – cellectis the	8	1.07%
18	– cellectis the “company”	8	1.07%
19	an oral presentation and	6	0.80%
20	– new york ny	6	0.80%
21	2023 – new york	6	0.80%
22	engineering for superior generation	6	0.80%
23	of ucart20x22 product candidate	6	0.80%
24	for superior generation of	6	0.80%
25	superior generation of car	6	0.80%
26	generation of car tcells	6	0.80%
27	of car tcells at	6	0.80%
28	in cancer immunology research	6	0.80%
29	international society for cellgene	6	0.80%
30	poster presentations at the	6	0.80%
31	oral presentation and two	6	0.80%
32	multiplex engineering for superior	6	0.80%
33	at an oral presentation	6	0.80%
34	european hematology association eha	6	0.80%
35	on june 27 2023	6	0.80%
36	and gene therapies today	6	0.80%
37	data at an oral	6	0.80%
38	clinical and translational data	6	0.80%
39	and translational data on	6	0.80%
40	at the european hematology	6	0.80%

#	URL	Whois	Check